POMT1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Our large cohort confirms the importance of type and location of each POMT1 mutation for the individual clinical manifestation and thereby expands the knowledge on the genotype-phenotype correlation in POMT1-related dystroglycanopathies.